Aggressive Leadership Drives Longhai Steel, Inc. (LGHS)

Longhai Steel, a rapidly growing producer of steel wire in and for China, has experienced tremendous annual revenue growth over the last few years, from $373,660 in 2009 to over 608,038 in 2011, due in no small part to the company’s aggressive executive management team and board of directors.

• Chaojun Wang (Chairman & CEO)
Mr. Wang has served as the Longhai’s Chairman and CEO since March 2010 and as CEO of the company’s variable interest entity Xingtai Longhai Wire Rod Co., Ltd. since its inception in 2008. He has also served as Chairman of Longhai Steel Group, the company’s related party, since 1999. Mr. Wang is also a member of the local parliament and holds a Bachelor’s Degree in Enterprise Management. He is currently also serving as Longhai’s Interim CFO.

• Steven Ross (Executive VP & Director)
Mr. Ross has over 25 years of senior management experience, ranging from high growth private companies to multi-billion dollar divisions of public enterprises. He is currently Managing Director of MTN Capital Partners, a New York-based private equity firm. Prior to joining MTN, Mr. Ross was CEO of National Investment Managers from 2006 until its sale to a private equity firm in 2011. Under his leadership, the company became the largest independent retirement services company in the country, with over $11 billion in assets under administration and operations in 17 cities in the United States.

• Dr. Michael Grieves (Director)
Dr. Grieves is a world-recognized expert in product lifecycle management, engineering, manufacturing, and information systems, and lectures worldwide on those topics. He has been the Managing Member of Michael W. Grieves, LLC since 2000 and was Research Professor of Oakland University between 2008 and 2009. Dr. Grieves has written extensively in both industry and academic periodicals and has served in executive, managerial, and entrepreneurial roles for over 40 years.

• Jeff Cooke (Director)
Mr. Cooke has been a CEO at multiple early-stage companies, and has held executive positions at Hewlett Packard, Apple Computer, and NEC. Mr. Cooke is currently President and CEO at Global Digital Strategies, Inc., which offers strategic executive leadership and specializes in providing the bridge from strategy to execution, primarily for early-stage companies and those undergoing a significant change in direction.

• Joseph ‘Josh’ Howell, III (Director)
Mr. Howell is currently Senior VP of Level 3 Communications, a global telecommunications company based in Colorado. Mr. Howell is part of the core team of executives who launched the communications company, listed it on NASDAQ, and helped build the company as it expanded to more than 45 countries. Prior to Level 3, he was Senior VP of MFS Communications, an international telecommunications company which he helped take public as part of the team of executives who built the company into the largest competitive local carrier in the U.S. and Europe.

For additional information, visit the company’s website at www.LonghaiSteelInc.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Wizzard Software Corp. (WZE) Completes Acquisition of Digital Entertainment International, Plans Name Change to FAB Universal Corp.

Yesterday, leading podcast network, Wizzard Software, announced that it has acquired Digital Entertainment International Ltd. (“FAB”), a leading distributor of digital entertainment media throughout Asia. FAB offers intelligent kiosks at 10,000 locations throughout China where consumers can purchase and download movies, music, television shows, and other forms of digital entertainment.

According to the definitive proxy statement filed by Wizzard with the SEC, dated June 15, 2012, FAB generated revenues of $55.5 million and net income of $11.5 million in fiscal 2010; in fiscal 2011, FAB generated $70.8 million in revenue and $14.7 million in net income. Wizzard expects the acquisition to boost its 2012 adjusted earnings per share and significantly affect its fourth quarter results.

“We are very pleased to have completed the acquisition of FAB and to begin this new chapter in Wizzard’s international development,” said Chris Spencer, Wizzard CEO. “Throughout this entire process we have been impressed with the expertise and dedication of FAB’s management team and associates and we expect this combination to create substantial value for our shareholders.”

He continued, “We are enthusiastic about combining Wizzard’s digital media distribution platform with FAB’s digital media distribution kiosk network in China, the world’s fastest-growing market. We believe this partnership creates one of the world’s premier digital entertainment media companies at a time when mobile computing is driving digital media consumption to the forefront of the entertainment industry.”

According to the acquisition agreement, Wizzard Software Corp. will change its name to FAB Universal Corp. and its ticker symbol will change to NYSE MKT:FU, effective October 9th, 2012.

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Pacer International, Inc. (PACR) Becomes First Logistics Company Ever to Be Named Business Partner of the Year by Procter & Gamble

Pacer International announced it has been named a “Business Partner of the Year” for 2012 by Procter & Gamble (P&G), which is the highest honor P&G gives to its suppliers and agencies.

Pacer, a leading freight transportation and global logistics services provider in North America, is the first logistics company to receive this honor from P&G. The company was among eight suppliers out of P&G’s more than 75,000 global suppliers to win the award, which Pacer received due to its demonstrated partner excellence through outstanding performance, as measured by P&G’s Supplier Performance Management System (SPMS). The P&G SPMS evaluates the performance of the company’s external business partners in the areas of commercial, operational, innovation, and relationship. Through the SPMS, P&G’s business partners are provided with a strict set of performance criteria that they must meet and maintain throughout the year.

The receipt of this distinguished award from P&G validates Pacer’s commitment to offering best-in-class customer service, as well as the company’s collaborative approach in providing innovative transportation solutions to P&G and its other customers.

The P&G organization is focused on its top business priorities, which include its external business partners, like Pacer, who help P&G innovate, more efficiently operate, and succeed in the marketplace.

Pacer International is a leading asset-light freight transportation and logistics services provider in North America. The company offers a wide range of services to promote the movement of freight from origin to destination through intermodal and logistics operating segments. The company’s intermodal segment provides container capacity, integrated local transportation services, and door-to-door intermodal shipment management. Pacer’s logistics segment offers truck brokerage, warehousing and distribution, international freight forwarding, and supply-chain management services.

For more information, visit the company’s Web site at www.pacer.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Power-One, Inc. (PWER) Introduces Certified Titanium Efficiency Power Supply

Power-One recently announced the introduction of a new product: the TET750-12-054NA, which uses proprietary Titanium Efficiency Technology. The TET has been certified by 80 PLUS to be of Titanium efficiency, which is performing at 96% efficiency at 50% load.

Based in Camarillo, CA, Power-One is focused on creating energy-efficient power conversion and power management systems for industries and products such as renewable energy, routers, data storage and servers, wireless communications, optical networking, medical diagnostics, and military applications, among others.

The TET, intended for use in servers, networking, and other redundant power applications, provides a single 12 volt output at 750 watts of output power. The unit also includes a 3.3 volt standby supply and PMBus communication. Less energy is consumed in the cooling infrastructure, meaning less power is wasted in the server unit overall, which is instrumental in Power-One’s stated goal of reducing the carbon footprint of the servers the TET is used in.

Power-One Chief Technology Officer Alain Chapuis, said, “This was a unique collaboration between our design centers in Switzerland and China. The extensive use of digital control and new energy saving circuit techniques has allowed us to achieve this unprecedented level of efficiency combined with a power density of 17.5 watts per cubic inch.”

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Cardium Therapeutics, Inc. (CXM) Addresses Significant International Market with Generx

Cardium Therapeutics’ Generx product candidate is a good example of the company’s strategy of acquiring and developing new and innovative bio-medical product opportunities addressing unmet medical needs on a worldwide basis.

Generx (alferminogene tadenovec, Ad5FGF-4) is a DNA-based angiogenic growth factor therapeutic for patients with advanced coronary artery disease. Basically, it stimulates the growth of supplemental collateral blood vessels in the heart, which enhances myocardial blood flow in heart patients. It involves a one-time intracoronary administration, using a standard cardiac infusion catheter, making it simple and cost effective to use. Unlike standard therapies for the heart, like nitrates and beta blockers that only provide transient relief of symptoms, Generx is a disease-modifying regenerative medicine that can result in structural and physiologic changes in the heart, specifically the growing of new blood vessels. It is being designed as a superior alternative for patients without access to or ability to pay for more costly and invasive surgical procedures to increase blood flow, a common problem in many countries with a less developed healthcare system. As such, Generx is currently being developed for international markets.

Generx has already been tested in clinical studies at more than one hundred medical centers in the U.S., Europe, and elsewhere, and is now part of a study in the Russia to evaluate its therapeutic effects on patients with myocardial ischemia due to coronary artery disease. The ASPIRE Phase 3 registration study is a controlled multi-center study conducted at up to eight leading cardiology centers in the Russian Federation, where the efficacy of Generx will be measured using rest and stress SPECT (Single-Photon Emission Computed Tomography) myocardial imaging to sensitively measure improvements in microvascular cardiac perfusion.

In addition to Generx and other products, the Cardium portfolio includes Excellagen, a new, FDA-cleared highly-refined fibrillar collagen-based topical gel (2.6%) designed to support favorable wound care management for use with diabetic and other ulcers, surgical and other wounds, as well as burns.

For additional information, visit www.CardiumTHX.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Entertainment Gaming Asia, Inc. (EGT) Dolphin Subsidiary Enters Philippine Gaming Market with $1.3 Million Order from the New Solaire Resort & Casino

Today, Entertainment Gaming Asia, a prominent gaming company with its focus on emerging gaming markets in Pan-Asia, announced that its Dolphin subsidiary has received a $1.3 million gaming chip order to supply the new Bloomberry Resorts Corp. (PSE: BLOOM) Solaire Resort & Casino in the Philippines. The order, which will be booked in the fourth quarter of 2012, marks Dolphin’s entrance into the burgeoning gaming market in the Philippines. A premier integrated resort, Solaire will be the first to open in Manila Bay’s highly anticipated Entertainment City casino and tourist complex in early 2013.

Dolphin is pleased to be expanding its market presence into the Philippines as the supplier of Solaire’s peso-dominated cash, non-negotiable, and reserve bank chips. Solaire’s order includes around 765,000 chips with a range of Dolphin’s high-level security features.

Entertainment Gaming Asia today additionally announced that its Dolphin subsidiary is currently in the process of delivering a previously announced order of RFID gaming chips and plaques to longtime customer Crown Perth, formerly known as Burswood Entertainment Complex, in Perth, Western Australia. This $2.2 million order – $1.6 million of which will be booked in the third quarter of 2012, with the remaining $600,000 booked in the fourth quarter of 2012 – includes more than 500,000 chips and 25,000 plaques as part of rebranding the property to the world-renowned “Crown” brand. Crown Perth, newly expanded and refurbished, is part of the integrated urban entertainment resorts owned by Crown Limited (ASX: CWN) and was launched at a gala event on Sept. 20.

Dolphin’s team worked collaboratively with Crown Perth to design a series of chips and plaques that will include the highest level of security features available, capturing the new branding to befit Crown Perth. The order further strengthens the company’s relationship with this prominent customer, demonstrating Crown Perth’s acknowledgment of the advanced quality and superior security features of Dolphin’s chips and plaques and their value for the price.

Entertainment Gaming Asia, a leading gaming company in Pan-Asia, is engaged in developing and operating casinos and gaming venues in the Indo-China region under its “Dreamworld” brand, as well as leasing electronic gaming machines to the gaming industry on a participation basis. The company additionally manufactures and sells RFID and traditional gaming chips and plaques to major casinos through Dolphin Products, its wholly owned subsidiary in Australia.

For more information, visit the company’s Web site at www.EGT-Group.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Analytical Report Points to Fundamental Strengths of SEFE, Inc. (SEFE)

Earlier this year, Grass Roots Research issued a strongly positive report on SEFE, a development stage company based in Colorado that has been developing proprietary technology to convert naturally occurring static electricity in the atmosphere into significant amounts of useable electricity. The energy extracted is pure electricity, requiring no energy-wasting conversion from a mechanical or solar input. It is simple, without expensive arrays of solar cells or massive wind farms. The report emphasized that SEFE’s core competency rested in its ability to leverage its patented energy capturing technology, giving it a strong market position and commensurately premium market valuation.

The principal points made by the report in support of SEFE include:

• SEFE has already been issued four patents by the USPTO, and has 18 other pending/provisional patent applications in process, all related to the energy extraction technology.
• SEFE possesses the technical competencies to develop a process for extracting the electricity at a low cost in comparison to conventional or alternative energy sources.
• There remains a continued long-term upward pressure on energy prices, encouraged in part by the growth in demand of developing countries such as India and China.

The report indicates that the key advantages to extraction and harnessing of atmospheric static electricity are 1) low cost technology to harness the energy; 2) high availability as an energy source, meaning electric extraction can take place night and day; 3) highly scalable process can be replicated across the globe; and 4) relatively fast deployment. More specifically, the report indicates that SEFE is expected to “efficiently manage operations and achieve significantly higher operating margins and net profit margins,” predicting revenues of $1.6 million for 2013, and more than $100 million by 2017.

For more information on SEFE, Inc., visit www.SEFElectric.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Direct Insite Corp. (DIRI) Describes e-Invoicing Platform Capabilities

Direct Insite, a cloud-based e-invoicing solutions company, today unveiled the enhanced discount management capabilities for its e-invoicing platform, Invoices On-Line.

The company’s discount management capabilities enable buyers to capture more discounts from suppliers, which are funneled into higher return rates and enhanced supplier relations. Direct Insite says this capability allows suppliers to increase cash flow, receive more predictable payments, and suffer less profit leakage from unearned discounts.

“Working capital management remains a top priority for companies. Invoices On-Line uniquely facilitates the management of early payment discounts between trading partners, improving cash flow across the entire financial supply chain,” Direct Insite president and CEO Matthew E. Oakes stated in the press release. “Our new functionality provides all users interactive reporting and real time cash flow analysis based upon available discounts, and it maximizes supplier participation by enabling targeted communication regarding discount offers.”

Invoices On-Line e-invoicing platform supports three discount platforms:

• Pre-determined discounts – suppliers can electronically submit invoices utilizing the Invoices On-Line portal;
• Early payment discount options – suppliers can choose from a set of discounts offered by buyers; and
• Dynamic request/renegotiation – allows suppliers and buyers to initiate a discount proposal to trading partners.

For more information visit www.directinsite.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Entropic Communications, Inc. (ENTR) Elected to RVU Alliance Board of Directors

The RVU Alliance has announced the election of Entropic Communications, Inc. to its board of directors, effective immediately. Entropic Co-Founder and Vice President of Technology Dr. Anton Monk will serve as the representative member for Entropic.

Currently an RVU Alliance member, Entropic has been an active supporter of the Alliance’s marketing and technical activities since the Alliance was created in 2009. Entropic also has longstanding partnerships across RVU Alliance’s ecosystem.

A global leader in semiconductor solutions for the connected home and the only pure-play platform semiconductor company in connected home entertainment, Entropic offers set-top box (STB) system-on-a-chip (SoC) and connectivity (MoCA, Broadband Access, and single-wire direct broadcast satellite outdoor unit) solutions that have given the company a keen understanding of the RVU Alliance’s target Pay-TV and supplier markets. Entropic’s STB SoC and MoCA technologies presently support the delivery of RVU technology.

Dr. Anton Monk’s considerable board experience will provide guidance to drive RVU forward as an important enabling technology to give consumers the same user experience for every TV in the home, as consumers in today’s market desire reliable and secure viewing and access to pre-recorded, live, premium, or personal content anywhere in the home and across any device. A higher level of strategic engagement at the board level will benefit both RVU and Entropic as they work cooperatively to advance the RVU standard, meeting new video delivery demands required by the convergence of broadcast and broadband networks.

Dr. Monk is an industry innovator in the video over coax connectivity market, as well as one of the co-founders of Entropic and the company’s current vice president of technology. He additionally serves on the MoCA board of directors and participates on various advisory boards, including the UCSD Corporate Affiliates Program, the EvoNexus Incubator, and the UCSD Electrical Engineering Department. Before co-founding Entropic, Dr. Monk took part in the development of cable, fixed wireless, and satellite integrated circuits (ICs) at Conexant and ComStream Corporation. He additionally spent time as a researcher at NASA’s Jet Propulsion Laboratory. Dr. Monk has a master’s of science degree in electrical engineering from The California Institute of Technology and a Ph.D. in electrical engineering from The University of California, San Diego.

RVU Alliance is a client/server-based technology that offers television viewers a consistent, pixel accurate server-generated user interface on a variety of consumer electronics devices. The RVU specification employs widely implemented UPnP and DLNA technologies to enable a gateway device like an advanced set-top box to work with non-proprietary client devices, such as connected TVs, Blu-ray players, and set-top boxes. The specification founded by Broadcom, Cisco, DIRECTV, Samsung, and Verizon is maintained by the RVU Alliance and facilitates the adoption of an open standard technology, allowing service providers to expand their unique UI and user experience onto standard consumer devices without the necessity of proprietary equipment.

Entropic Communications is a world leader in providing silicon and software solutions that enable connected home entertainment. Entropic transforms the way traditional HDTV broadcast and streaming video content is seamlessly, dependably, and securely delivered, processed, and distributed into and throughout the home. The company’s pioneering home connectivity and set-top box system-on-a-chip solutions allow Pay-TV service providers to give consumers whole-home multimedia content that is more engaging.

For more information, visit the company’s Web site at www.entropic.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Wave Systems Corp. (WAVX) Enters ARM TrsutZone Ready Program

Wave Systems, a foremost expert on the growing trend of incorporating data protection directly into endpoint computing platforms, announced that it has joined the ARM TrustZone® Ready Enablement Program. The goal of the program is to deliver support and infrastructure for the implementation of enterprise security capabilities in mobile devices. This partnership means that Wave has united with other industry leaders in helping chip manufacturers design and roll out new industry standard security capabilities within ARM’s TrustZone architecture to enable full cross-platform interoperability across PCs, tablets, smartphones, and other mobile devices.

ARM, the leading semiconductor IP supplier worldwide, developed TrustZone Technology as a System-on-Chip security concept that features a hardware-isolated space for a Trusted Execution Environment (TEE). Mobile services can be deployed with enhanced security and convenience after core security services, such as cryptography, storage, and user interfaces, have been integrated.

ARM’s TrustZone Ready enablement program has the primary objective of assisting chip and device manufacturers in designing robust, industry-certified security architecture into their products that will address the demands of service providers seeking to deploy secure services on secured platforms. Companies that have security blanketed across their entire system will significantly benefit from the cohesive set of design blueprints, market requirements, and checklists aligned with industry standards inherent to the program.

“Smart phones, tablets and other devices are essential for today’s enterprise, and require access to sensitive applications and data. While these devices have excellent security for the mobile operator’s services, they lack basic security for use within an enterprise network,” commented Steven Sprague, Wave’s CEO. “ARM, with the TrustZone Ready Program, is taking the lead in making sure that standards-based security implemented in the TrustZone Trusted Execution Environment (TEE) is integrated into chipsets for mobile devices. Wave is committed to sharing its expertise in Trusted Platform Module (TPM) implementations, application development and trust infrastructure support.”

“Wave’s infrastructure for managing TPM and TPM-mobile-enabled devices will allow enterprise users to exploit the full capabilities of Trusted Computing Group standards across multiple device types,” added Jon Geater, Director of Technology for ARM Secure Services Division and Board Representative of ARM at GlobalPlatform. “ARM welcomes Wave into the TrustZone Ready Program as a valuable partner that will bring secure enterprise services to TrustZone secured devices running GlobalPlatform Trusted Execution Environments.”

For further information, please visit www.wave.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Kendall D. Gill Appointed to GlobalWise Investments, Inc. (GWIV) Chief Financial Officer Position

Before the opening bell this morning, GlobalWise Investments and its wholly owned subsidiary Intellinetics, a leading-edge technology company focused on the design, implementation, and management of cloud-based ECM systems in both the public and private sectors, reported the appointment of Kendall “Ken” D. Gill as Chief Financial Officer of GlobalWise. According to the release, he will remain a member of the Board of Directors, Executive Vice President, Chief Technology Officer, and Treasurer of GlobalWise.

Mr. Gill brings more than four decades of experience in the fields of public accounting and finance, as well as expertise gained from business development and various entrepreneurial endeavors. Previously he served as Audit Manager at Coopers and Lybrand, where he also functioned as an accounting instructor at the Coopers and Lybrand National Schools throughout the United States. Mr. Gill has also been CFO of companies within several different industries, including restaurant, automotive, and chemical. Most recently, Mr. Gill served as an accounting contractor to GlobalWise to assist in the transformation from a privately owned company to publicly held company.

“We are proud to announce Ken Gill as Chief Financial Officer of GlobalWise,” commented William J. “BJ” Santiago, CEO of GlobalWise. “Ken has a wealth of public accounting experience across a wide variety of sectors and disciplines. During the past 12 months, Ken, as an accounting contractor, has been a key part of meeting our accounting and financial responsibilities. Ken did a fantastic job in working with our legal, audit and SEC compliance teams to prepare us to enter the public market.”

“I am excited to formally join the GlobalWise team as CFO and to continue working with the senior management team,” added Ken Gill, CFO of GlobalWise.

In addition, Mr. Gill is a decorated US States Army officer, having served in Vietnam with the 173rd Airborne and acted as a senior advisor to the Vietnamese Airborne, Military, and Government during the conflict.

For additional information on GlobalWise Investments, visit the company’s website at www.GlobalWiseInvestments.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Longwei Petroleum Investment Holding Ltd. (LPH) Completes Acquisition of Huajie Petroleum Assets

Longwei Petroleum is an energy company engaged in the storage and distribution of finished petroleum products in China. The company has a storage capacity of 220,000 metric tons at three locations in Shanxi Province, China. It delivers products, at competitive prices, to transportation companies, coal mining firms, power supply customers, and gas stations.

The company was recently named to the Forbes list of “Asia’s 200 Best Under a Billion” from a pool of 15,000 companies. Forbes ranked the companies based on sales growth, earnings growth, and return on equity in the past 12 months and over three years. Longwei’s three year track record is 45% sales growth, 28% earnings per share growth, and 28% return on equity.

Longwei Petroleum today announced that it has finalized the $110.6 million purchase of the assets of Huajie Petroleum Company Limited, a fuel storage depot in northern Shanxi Province with a 100,000 metric ton storage capacity. The other assets involved in the transaction include accessory facilities and equipment, delivery and distribution platforms (including a rail spur), a vehicle loading and unloading station, and an office building and land.

With the addition of the Huajie storage facility, Longwei will have strengthened its lead as the biggest non-state-owned fuel storage and distribution business in Shanxi Province. The company will also be better positioned to capitalize on the demand for petroleum products in its regional market and quickly ramp up sales. Northern Shanxi Province is a fast-growing industrial area of China.

For additional information about Longwei Petroleum and its business, please visit the company’s website at www.longweipetroleum.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Echo Therapeutics, Inc. (ECTE) is “One to Watch”

Echo Therapeutics is a transdermal medical device company with extensive expertise in advanced skin permeation technology. In particular, the company is developing the PreludeTM SkinPrep System to allow for painless and significantly enhanced skin permeation that will enable both needle-free drug delivery and analyte extraction, plus the Symphony tCGM System, a non-invasive, wireless, transdermal continuous glucose monitoring system for use in hospital critical care units and for people with diabetes.

The skin permeation technology utilized is based upon Echo’s patented feedback control algorithm, which allows system removal of only the outermost layer of dry dead skin cells, painlessly preparing the skin for optimal permeation. The whole process is designed as a safe, effective, fast-acting, and pain free platform for needle-free drug delivery as well as for the pain-free extraction of analytes used for things like glucose monitoring.

The ability to painlessly monitor glucose levels will allow Echo to tap into the huge and growing global diabetes market. The cost of diabetes care in the U.S. alone is, according to the ADA, more than $174 billion, based upon a 2007 figure, including medical expenditures and lost productivity. The ADA estimates that people with diabetes average medical expenditures more than twice as high as those without diabetes, and that nearly 10% of all healthcare dollars can be attributed to the disease. In addition, a significant portion of overall diabetes care costs go to blood glucose monitoring.

Echo currently has two key strategic partnerships in place:

• Ferndale Pharma Group, Inc. and its wholly owned subsidiary Eloquest Healthcare Inc. have been licensed by Echo to develop, market, and sell the Prelude device for enhanced, fast acting, and needle-free delivery of Ferndale’s topical lidocaine product in North America and the U.K.

• Handok Pharmaceuticals Co., Ltd. has been licensed to develop, market, and sell the Symphony® tCGM System for continuous glucose monitoring in South Korea.

For additional information, visit the company’s website at www.EchoTX.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Successful Results Announced for Antares Pharma’s (ATRS) Actual Human Use Study of VIBEX MTX

Yesterday, Antares Pharma announced positive results from its actual human use (AHU) study of VIBEX Methotrexate (MTX). The multicenter, open-label, single-arm, in-clinic study was conducted to evaluate the actual human use of MTX when administered through the VIBEX Medi-Jet in adult patients suffering with rheumatoid arthritis (RA).

The study’s primary objective was assessing the safe usability of VIBEX MTX for self-administration parenteral MTX in adult RA patients, following standardized training by site personnel and patient review of written directions. The study’s secondary objectives included evaluating the reliability, user-friendliness, and robustness of the VIBEX Medi-Jet; determining the safety and local tolerance of Medi-Jet-administered MTX; and gauging the effectiveness of patient education tools, including written instructions.

The AHU study included three visits over a nine-day period, as well as a screening period, a treatment period and a follow-up visit. In all, 101 patients were enrolled in four study dose groups: 10 mg. (n=20), 15 mg. (n=30), 20 mg. (n=31) and 25 mg. (n=20). Patients self-administered the single MTX dose using the VIBEX Medi-Jet.

The study’s results show that self-administration of MTX using the VIBEX Medi-Jet is safe and well-tolerated. After receiving standardized training from site personnel and reviewing written instructions, all 101 patients were able to successfully perform the self-administration. Additionally, the VIBEX Medi-Jet functioned properly and as intended for all administrations – showing dependability and robustness. As indicated on the “Ease of Use” questionnaire, 98 percent of patients found the VIBEX Medi-Jet to be easy to use, and all patients found the instructions and training clear and simple to follow. At the conclusion of the treatment period, patients were asked about site administration pain, which was measured using a 100 mm visual analog scale (VAS). The results showed that patients experienced minimal or no pain, with a mean value of 3.6 mm on a scale of 100 mm. Most importantly, no treatment-emergent serious adverse events related to the drug were experienced by patients.

The study demonstrated that RU patients can successfully self-administer MTX with the VIBEX Medi-Jet, and the study’s findings keep Antares Pharma on track to file a New Drug Application for VIBEX MTX in early 2013.

Focused on self-administered parenteral pharmaceutical products and topical gel-based medicines, Antares Pharma has technology platforms that include VIBEX disposable Medi-Jet, disposable multiuse pen injectors, and Vision reusable needle-free injectors marketed as Tjet and Zomajet. Antares Pharma has product marketing agreements with various companies, including Teva Pharmaceutical Industries Ltd., Ferring Pharmaceuticals, Watson Pharmaceuticals, and Jazz Pharmaceuticals. Antares Pharma operates two U.S. facilities: Parenteral Products Group in Minneapolis, Minn., and Product Development Group and corporate offices in Ewing, N.J.

For more information, visit the company’s Web site at www.antarespharma.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

ORBCOMM, Inc. (ORBC) Subsidiary Provides Refrigerated Transportation with TMW Software

StarTrak Information Technologies, a subsidiary of ORBCOMM, recently announced that the company has teamed with TMW Systems to implement StarTrak’s ReeferTrak application with TMWSuite software at joint customer, Lessors, Inc.

StarTrak is focused on delivering information technology to the transportation industry, specifically refrigerated transportation systems. StarTrak has successful relationships with several refrigerated unit manufacturers such as Carrier and Thermo King, with customers including Tropicana, Maersk Line, Prime Inc, CR England, FFE Transport, and Exel Transportation.

ReeferTrak interfaces with TMWSuite to capture real-time refrigerated trailer operational data, including trailer temperature, operational condition, and GPS position, information invaluable to the carriers and fleets that will utilize it. The range of reefer-specific data available to Lessors will also include temperature set point, on/off state, location, temperatures, fuel levels, and microprocessor controller alarms.

David Gsell, StarTrak GM, said, “This joint capability from StarTrak and TMW offers timely and comprehensive temperature, fuel management, maintenance, and logistical applications services to help carriers operate more effectively and efficiently. TMWSuite customers can leverage the StarTrak interface for continuous visibility and full two-way control over their fleet, maximizing real savings, improving end-to-end operations and ultimately providing better service throughout the value chain.”

“The customer-proven integration with StarTrak provides our cold chain for-hire carrier customers with leading tracking and monitoring capabilities for transport refrigeration units,” added Jennifer McQuiston, Director, Partner Management, TMW Systems. “TMW customers who are active in food and temperature-controlled logistics operations now have extensive options for trailer tracking and fleet management with this announcement.”

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

DreamTeamGroup to Provide Social Media Coverage of 2012 Aegis Healthcare Conference

Earlier today, DreamTeamGroup announced that it will be working with Aegis Capital to provide the investment community with ongoing social media coverage of the upcoming 2012 Aegis Healthcare Conference to be held September 27-29, 2012, at the Wynn Resort and Casino in Las Vegas.

Michael McCarthy, Managing Director of DreamTeamGroup, stated, “DreamTeamGroup will utilize its family of business brands to reach the hundreds of thousands of investors who follow us at various social networking sites. In addition to posting blogs and status updates on attending companies as they begin their presentations, we will be sending a special newsletter profiling the event to our subscribers.”

“DreamTeamGroup will be a key part of this week’s conference as the official social media relations sponsor,” Jonathan Keim, DreamTeamGroup’s Director of Communications, commented. “We are very excited to be providing investors at the event and those joining online with real-time coverage of the healthcare conference.”

A consortium of unique marketing brands targeted towards investors, DreamTeamGroup combines very different, but complementary marketing avenues into one dynamic approach. This interlocking marketing convergence tackles many obstacles in the marketing process by engaging many different types of individuals with compelling content. By providing unique offerings, DreamTeamGroup has become a valuable advertising outlet garnering a top placement in traffic and unique hits.

To learn more about DreamTeamGroup, visit www.DreamTeamGroup.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

VistaGen Therapeutics (VSTA) Stem Cell Initiatives Led by Bio-Oriented Management Team

South San Francisco, California-based VistaGen Therapeutics has developed a versatile stem cell technology platform based on the controlled differentiation of human pluripotent stem cells into multiple types of mature, non-transformed cells, as a source for creating unique and superior bioassay systems for predicting potential heart and liver toxicity issues of new drug candidates. The company was co-founded by Dr. H. Ralph Snodgrass, who now serves as VistaGen’s President and Chief Scientific Officer, and Dr. Gordon Keller, now Chairman of VistaGen’s Scientific Advisory Board and Director of the prestigious University Health Network’s McEwen Centre for Regenerative Medicine in Toronto.

Dr. Snodgrass has over 18 years of senior biotechnology management experience, and more than 10 years of direct research experience. He is a past Board Member of the Emerging Company Section of the Biotechnology Industry Organization (BIO), and is a published and recognized pioneering expert in stem cell biology with more than 20 years’ experience in the uses of stem cells as biological tools for drug discovery and development. Dr. Keller, one of the world’s leading stem cell researchers, has been named a “Top 25 Transformational Canadian” for his stem cell research.

In 1998, Dr. Snodgrass and Dr. Keller decided to work together in support of the vision of using human stem cell technology to transform drug development. Their idea of bringing the element of human biology to the front in the drug development process was ahead of its time. Their work has led to the use of heart cells for predicting potential heart toxicity, and is now leading to the use of liver cells for predicting potential liver toxicity and metabolism issues. Their accomplishments are now supported by novel bioassay systems with game–changing potential.

In addition to Dr. Snodgrass, VistaGen’s experienced management team includes,

• Shawn K. Singh, J.D. (CEO, Director), with over 20 years of experience serving in senior management roles with successful public and private biotechnology and pharmaceutical companies, a biotechnology-focused venture capital firm, and a profitable contract research and development organization. Companies include Cato BioVentures, Cato Research, Echo Therapeutics (Nasdaq: ECTE), and SciClone Pharmaceuticals (Nasdaq: SCLN).

• Jerrold D. Dotson, CPA (CFO), formerly Corporate Controller for Discovery Foods and Vice President of Finance and Administration and Corporate Secretary for California & Hawaiian Sugar Company and The Clorox Company.

• A. Franklin Rice, MBA (VP, Corporate Development), with nearly 25 years of biotechnology industry experience, including as Senior Director of Business Development at Genencor International and as Vice President of Biotechnology and Pharmaceuticals for Bechtel Group.

For additional information, visit the company’s website at www.VistaGen.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Adventrx Pharmaceuticals, Inc. (ANX) Video Chart for Wednesday, September 26, 2012

ANX has been in a solid uptrend since the end of June, regularly making higher lows. Yesterday’s 4.85 percent climb to close at 83 cents has the chart once again at a resistance point. The stock should be closely watched for a break that could lead to a challenge of 52-week highs at $1.16.

To view the video chart, visit the following link: http://www.missionir.com/videos.html

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

GreeneStone Healthcare Corp. (GRST) Leading a Private Healthcare Revolution

Although GreeneStone Healthcare was incorporated in Colorado in 1993, its operations are in Ontario, Canada, where it operates clinics and facilities providing a variety of healthcare services. GreeneStone has developed a special focus on helping organizations maintain and enhance the effectiveness and well-being of their executive workforce, with programs supporting both physical and mental well-being, including endoscopy, cardiology, diabetes, addiction, nutrition and weight loss, as well as gastrointestinal and eating disorders. Offering a one-stop integrated and holistic approach ensures the most satisfying patient relationship, representing a positive corporate selling point for executives, while also reducing long term corporate healthcare and disability costs.

Public healthcare systems are stretched providing basic physical services, with companies and the public increasingly looking for private alternatives. Particular healthcare niches, such as mental health and well-being, are notoriously underserved. GreeneStone is leading the move toward private services that offer more than simply overflow capacity for public health systems.

GreeneStone’s Addiction Treatment Center located in Muskoka, Ontario, is an example of the dramatic difference in treatment available outside of the public system options. Located in a resort style setting on 43 acres, the environment is inviting and non-institutionalized to maximize the healing and recovery process. The facility is fully staffed with physicians, psychiatrists, psychologists, therapists, nurses, nutritionists, and even physical fitness experts, all working collaboratively to produce the best holistic treatment outcomes. It’s an unmatched opportunity for working professionals to heal, rest, and recover, while under the care of a multidisciplinary team of skilled and experienced professionals. The care is individualized and dignified, designed to lessen the suffering for both patients and family members dealing with the addiction process.

The success of the GreeneStone approach has led to its continued expansion, with the opening of a second colonoscopy clinic in Toronto and the expansion of its gastrointestinal and eating disorder teams. New partnerships are being formed to provide additional services for faster growth. GreeneStone has seen positive revenue growth over the past seven quarters as the company’s Muskoka facility has ramped up operations.

For additional information, visit the company’s websites at www.GreeneStoneClinic.com and www.GreeneStoneInvestor.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

CNET Awards Support.com, Inc. (SPRT) SUPERAntiSpyware with “Spectacular” 5-Star Rating

Technology and service provider, Support.com, recently announced that CNET granted their popular anti-malware program, SUPERAntiSpyware 5, a 5-star rating.

SUPERAntiSpyware 5 has become a popular choice among consumers as a way to supplement their standard antivirus programs. The anti-malware application is designed to complement, not replace, existing security software. With the prevalence of spyware, malware, Trojans, and other high-risk computer viruses, companies can never be too careful when insulating themselves from risk. Support.com’s software provides a solution to this problem.

In addition to CNET’s 5 star rating, a recent review by Download.com praised SUPERAntiSpyware 5 for its ability to “find and annihilate plenty of other pests,” including keyloggers, rootkits, hijackers, and bots, effectively providing a powerful added layer of defense.

These are not the first glowing recommendations for SUPERAntiSpyware 5, which has received several positive reviews from other industry leaders, such as Notebooks.com who said, “If you need help in keeping malware off your computer, or need to remove malware, SUPERAntiSpyware 5 is a good solution.”

Another reviewer, Jacob Erdei of AntiVirusreviews.com, said of SUPERAntiSpyware 5, “This will make a GREAT secondary scanner and line of protection for your computer….I will personally be using this client going forward to run secondary scans on my computer to ensure I’m malware and virus free.”

Currently, SUPERAntiSpyware 5 comes in two versions: 1) SUPERAntiSpyware Free Edition – the basic edition which offers exceptional malware detection and removal; and 2) SUPERAntiSpyware Professional Edition – a step further by adding real-time protection, automatic definition updates, and scheduled scanning capabilities. Both versions are available for download from partner sites such as CNET Downloads or directly from www.SUPERAntiSpyware.com.

For more information on the NASDAQ-listed company behind this award-winning security software, visit www.support.com.

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

EMCORE Corp. (EMKR) Wins Solar Panel Manufacturing Contract from Orbital Sciences

EMCORE is a leading provider of compound semiconductor-based components and subsystems for the fiber optic and solar power markets. The company is also the world’s leading manufacturer of efficient, radiation-hard solar cells for space power applications, such as earth orbiting satellites and interplanetary spacecraft.

The company today announced that it has been awarded a solar panel manufacturing contract by Orbital Sciences Corporation for NASA’s Ice, Cloud, and land Elevation Satellite-2 (ICESat-2) mission targeted for launch in early 2016. The mission builds on measurements taken by NASA’s previous ICESat mission for measuring ice sheet mass balance (which showed thinning of the world’s ice sheets), cloud and aerosol heights, as well as land topography and vegetation characteristics.

Solar power panels populated with EMCORE’s most advanced ZTJ triple-junction solar cells will power the ICESat-2 spacecraft, manufactured by Orbital Sciences. With a beginning-of-life (BOL) conversion efficiency nearing 30% and the option for a patented, onboard monolithic bypass diode, EMCORE’s industry-leading multi-junction solar cells provide the highest available power to all types of spacecraft.

The company has become the supplier of choice for demanding spacecraft power system and has formed a mutually beneficial partnership on many occasions with Orbital Sciences. For more information about EMCORE Corporation and all its businesses, including powering spacecraft, please visit the company’s website at www.emcore.com.

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Extreme Networks, Inc. (EXTR) Names Nancy Shemwell as EVP of Global Sales

Extreme Networks, a technology company focused on high-performance Ethernet switching for cloud, data center, and mobile networks, has appointed Nancy Shemwell as executive vice president of global sales, where she will lead the company’s sales and channel management teams through global expansion initiatives.

With 20 years of experience in high-performance transformational global sales forces behind her, Shemwell will focus on executing the company’s goal of establishing and seeking out new avenues to the cloud, data center, enterprise, and mobility markets.

“Nancy brings to Extreme Networks the leadership skills, relationships and proven sales experience that can help us drive towards our revenue and operating income goals,” Oscar Rodriguez, president and CEO of Extreme Networks stated in the press release.

Shemwell’s previous positions include that of president and CEO of Multi-Link; executive vice president of global sales at Symmetricom; and a 16-year career with Nortel Networks, where she served as president of Micom Communications Corp. (a Nortel data subsidiary), vice president of business segments, and vice president of sales and marketing for Wiltel (Nortel’s largest distributor).

Extreme Networks new EVP currently serves on the board of directors for the North Texas Regional Center for Innovation and Commercialization, VoodooVox Inc., and is an associate board member for Southern Methodist University’s (SMU) Cox School of Business.

For more information visit http://www.extremenetworks.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

DragonWave, Inc. (DRWI) Announces Successful Field Tests Using 2048 QAM Radios in Intertelecom Network Deployment

DragonWave, a prominent supplier of packet microwave radio systems for mobile and access networks worldwide, announced today that field tests have been completed on its Horizon packet microwave products and the results have confirmed the functionality of higher modulation modes up to 2048 QAM. The tests were conducted in Odessa, Ukraine, the nation’s south Bay City. DragonWave worked in coordination with its in-country partner UKROM and their customer, Intertelecom, on the deployments and analysis for the field test. Intertelecom is one of the largest wireless service providers in the country.

Throughout field-testing, the higher modulation of the Horizon products established the radios’ ability to transport as much as 37 percent more data through existing microwave channels. An improvement of this magnitude will significantly improve spectral efficiency, as well as lower the operator’s cost per bit. The testing was done in concert with dual channel operation and DragonWave’s unique Bandwidth Accelerator feature. These two features, in conjunction with the higher modulation, more than tripled the capacity to more than 1.3 Gbps in this test.

DragonWave is the first packet microwave supplier to offer the cutting edge 2048 QAM radios. These improved radios provide mobile operators tested and proven radios with significantly more total link capacity compared to competitive products. A simple software download is all it takes for customers to acquire this new capability. All Horizon packet microwave radios support Hitless Automatic Adaptive Modulation, bringing operators the benefits of increased capacity by using higher modes when link properties permit-even on existing links that have been designed for lower modulation modes.

To date, DragonWave has shipped over 800 Horizon links to Intertelecom through its local integration partner, UKRCOM.

“We explored other options for increasing link capacity such as XPIC, but we soon realized that DragonWave’s solution of coupling higher modulation modes with Hitless Automatic Adaptive Modulation allows us to meet the growing backhaul demands without needing to re-engineer existing links or purchase additional radios,” said Boris Akulov, CEO at Intertelecom. “In effect, we have found a very cost efficient and streamlined means to triple our network capacity.”

With 2048 QAM, customers can achieve greater than 500 Mbps of transport in a Horizon Compact+ all-outdoor system and up to 1 Gbps when DragonWave’s Bandwidth Accelerator compression technology is included. Horizon Quantum can deliver two carriers per radio, each capable of higher order modulation and compression, delivering up to 2 Gbps in a single radio.

“The successful field testing of 2048 QAM marks another milestone in DragonWave being first to market with technology and innovation that sets us apart from the competition,” said DragonWave CEO Peter Allen. “We congratulate our Ukrainian customers on their performance results and are encouraged to be expanding our market share in an important and growing region for microwave transport.”

For further information, please visit www.intertelecom.ua

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Naval Air Warfare Center Training Systems Division Awards Kratos Defense & Security Solutions, Inc. (KTOS) with Major Contract

Kratos Defense & Security Solutions announced that it has been awarded a contract for the Naval Air Warfare Center Training Systems Division’s (NAWCTSD) Training Data Products Contract (TDPC), a Multiple Award Contract (MAC). Kratos is a specialized National Security technology business that provides mission critical products, services, and solutions for United States National Security. The awarded contract has a ceiling value of $780M and an eight-year ordering period. The contract will provide the Naval Air Systems Command Team with a streamlined, quick reaction vehicle for the acquisition and life cycle support of Training Data Products (TDP) for its many customers across the U.S. Navy, Department of Homeland Security, and Foreign Military Sales.

“This is a key contract vehicle for the Navy and other armed services and provides new opportunity for our training solutions across the Navy’s aviation, surface, undersea, and cross-warfare domains,” said Phil Carrai, President of Kratos Technology and Training Solutions. “This award builds on our other recent training-focused IDIQ awards, including NTPS and TSC III, placing Kratos in a dynamic position both to reach new customers and better serve our existing clients.”

Kratos’ award supports competing for task orders across all TDPC functional areas, including:

• Analysis, Design and Evaluation
• Development, Production, and Implementation;
• Sustainment

Self-paced training, group-paced training, dual-purpose training, blended training, learner assessments, and performance support systems will all be included in the contract. The TDPC MAC is intended to support training system ISD requirements of Naval Air Systems Command’s Aviation Training Systems Program Office, as well as the four NAWCTSD Program Directorates (Aviation, Surface, Undersea, and Cross-Warfare/International).

“Kratos brings a highly experienced team with proven knowledge and demonstrated execution ability across the full spectrum of training development,” said Dan Dunaway, Senior Vice President of Kratos Training Solutions. “Kratos has an extensive track record of providing advanced training solutions to the U.S. Navy as well as the other uniformed services. We look forward to applying this knowledge and experience to developing the next generation of training solutions to enhance the readiness and performance of our nation’s Warfighters.”

Kratos, a leading National Security Solutions provider, has core capabilities including sophisticated engineering, manufacturing, and system integration offerings for National Security platforms and programs. Kratos’ specializes in Command, Control, Communications, Computing, Combat Systems, Intelligence, Surveillance, and Reconnaissance (C5ISR), satellite communication systems, unmanned systems, cyber warfare, cybersecurity, information assurance, and critical infrastructure security. The majority of Kratos’ work is performed on a military base, in a secure facility or at a critical infrastructure location. Kratos’ primary end customers are national security related agencies.

More information can be found at www.KratosDefense.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Zacks Positive Coverage of Duma Energy Corp. (DUMA) Indicates Company’s Successful Model

When Zacks Investment Research recently initiated coverage on Duma Energy, giving the company an Outperform rating based upon its profitability and rapidly growing revenue, it was a vote for the company’s overall strategy of supporting less certain exploratory efforts with an established and predictable flow of income from domestic producing wells. Instead of the common condition of energy exploration companies, founded upon little more than a loan and some prospects, Duma has put together a team of industry pros experienced enough to know a smarter way. By successfully identifying and developing a series of producing wells, primarily in the shallow waters of Houston’s Galveston Bay and Trinity Bay, Duma has built up a dependable source of income.

Duma produced 38,000 barrels of oil equivalent (boe) in fiscal 2011, and produced over 45,000 boe in the first half of fiscal 2012, with year-over-year revenue growth exceeding 500%. With operating margins already approaching 50%, and improving as new wells and production efficiencies increase, the company’s financial foundation continues to grow. They are now sitting on over $77 million in proven reserves (discounted), with less than $12 million booked reserves.

It’s an income stream that has provided Duma the time and backing to explore at their own pace, letting them apply their well-established geological expertise and industry contacts to opportunities overlooked or unavailable to others. An example is their recent acquisition of Namibia Exploration, now a wholly owned subsidiary, giving Duma a working interest in a 5.3 million acre petroleum concession in Namibia, Africa. The Owambo Basin, site of the concession, extends into Angola, one of the continent’s major oil producing countries. The Basin appears to have the elements of a major petroleum system.

For additional information on Duma Energy, visit the company’s website at www.DUMA.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

ShorTel, Inc. (SHOR) Named a Winner at MES West 2012 Xcellence Awards

Leading provider of unified communications platforms, ShoreTel announced today that it has been named a winner at the Midsize Enterprise Summit (MES) West 2012 XCellence Awards in the categories of Best Midmarket Software Solution, Best Demonstration of ROI, and Best Execution of a Midmarket IT Solution.

The Midsize Enterprise Summit XCellence Awards, sponsored by XChange Events, measure the overall perception of vendors’ products/services, presentations, and presence during MES West. ShoreTel showed its prowess in the industry through demonstrating products that eliminate complexity in communications. With ShorTel, CIOs can focus their resources on their critical areas of business and use collaboration solutions to help their teams communicate effectively using any device in any location. By winning the prestigious XCellence Awards, ShoreTel continues to demonstrate its commitment to understanding the unique needs of the midsize enterprise IT market.

Kevin Gavin, ShorTel’s chief marketing officer, remarked, “To demonstrate ShoreTel’s brilliant simplicity in action at the show, [we] provided a complete integrated communication experience live in front of the audience. This included our IP telephony capabilities with IP 655 desk phones, live system administration capabilities with ShoreTel’s Director Web application adding audience members as new users with all services in seconds, and demonstrating the intuitiveness and ease of use with our conferencing and collaboration with Macs and PCs, along with integrated ShoreTel Mobility software on Apple iPhones, iPads and Android Smart phones.”

The awards were presented at the JW Marriot in San Antonio, TX, from Sept. 12-14, 2012. MES West 2012 brought together industry experts and practitioners to discuss the specific needs of the midmarket and how to best drive IT innovation despite an environment of tight cost control. The conference provided IT executives with exclusive access to industry research, thought provoking keynote sessions, interactive boardroom appointments, a solutions pavilion featuring exhibitors from both emerging and established vendors, as well as peer to peer networking opportunities.

“The midmarket has its own unique set of challenges and opportunities,” said Robert C. DeMarzo, Senior Vice President of Strategic Content, XChange Events. “The XCellence Awards recognize the vendors who understand those market nuances and provide the best solutions to meet this market’s evolving needs. We congratulate all the winning companies for their ongoing commitment to innovation and customer satisfaction.”

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Longwei Petroleum Investment Holding Ltd. (LPH) Doubles Storage Capacity, Gains Key Footprint in Northern Shanxi via Huajie Deal

Longwei Petroleum has a large, established presence in gasoline (#90 and #93 commercial blends, as per Chinese Gasoline Grading System), diesel (#10), fuel oils destined for furnaces/boilers, and even unrefined petroleum products like solvents for a variety of end markets. The main corporate HQ and storage facility is in Taiyuan City, at the heart of the PRC’s coal nexus, thriving Shanxi Province and the company has additional infrastructure in nearby Gujiao as well.

The booming vehicle and industrial end markets in Shanxi make today’s announcement by Longwei, that it will wrap up the Huajie Petroleum Co., Ltd. petroleum asset purchase by the end of the month, very exciting. Tacking on another 100k metric tons of storage capacity in the deal via the critical infrastructure in northern Shanxi, LPH and shareholders will be getting a sweet deal at roughly $110.6M, with 78.6% of the sum already paid and only a final, $23.7M payment remaining (slated for on or before the 30th of the month).

The total asset package is in a perfect site, Xingyuan Township, Fanshi County. This is just south of the main train station in northern Shanxi and with all of the necessary accoutrements on hand, from the storage tanks to ancillary facilities and hardware for delivery/distribution, including a dedicated rail spur with loading station, LPH has easily acquired a solid footprint in the center of the northern Shanxi market. There is even ample space (3k square meter office building) for the other major component of LPH’s business, customer service, which has proven to be a real secret of the retail success story. 98 acres of land use rights adjacent to the main rail line are also included in the deal.

Longwei has been making quite a name for itself in recent years and the recent fiscal 2012 data makes it no surprise, with revenues up 6% to $510.6M ($256.3M from Taiyuan and $233.8M from Gujiao) compared to FY11 and GAAP net income attributable to common shareholders of $65.1M, the book value per share is up to $3.31, as stockholders equity increased some 27.4% to $71.8M. Raw performance data like that, set against the backdrop of Shanxi’s 2011 GDP growth rate of 13%, should tell investors everything they need to know about the shrewdness of LPH management. With the local provincial government okaying another $158B for local development projects, in line with the PRC’s regional industrial stimulus plan, and an impressive $790B fixed asset investment envelope estimated for Shanxi over the next five years, Longwei is clearly doubling down on the province’s demonstrably valid growth vector.

The company made the cut out of 15k companies to place on the Forbes influential Asia’s 200 Best Under a Billion list for their exceptional sales/earnings growth and return on equity over the last 1-3 years, with a reported 45% growth in sales, a jump of 28% in the EPS, and a 28% jump in return on equity for the three-year period. These figures are driven by rapid turnover, timely delivery to a wide array of clients, as well as agency fees cleared via purchasing agent operations in the complex and bustling Shanxi regional market.

Chairman and CEO of LPH, Cai Yongjun, noted the execution of the deal without dilution to the shareholder base and expressed the confidence held by management that a cash close, backed up by logistical throughput gained in the deal, was the top momentum-maintaining decision for LPH.

CFO of LPH, Michael Toups, underlined this point and explained to investors that the company has been working very hard to balance working capital and exploit opportunities in the market price of petroleum in order to stitch up this deal at a great value. Toups further underscored the strong inventory and cash flow positions from Q1 FY13 data, affirming confidence in the Huajie asset purchase’s timing held by management. Toups also pointed to the company’s masterful work with the Gujiao facility since 2010, as the company has successfully ramped the facility up to a point where it now accounts for some 48% of total product sales.

The deal almost doubles storage capacity for LPH to 220k metric tons while capturing a key stronghold in northern Shanxi’s burgeoning industrial market, placing Longwei into an even bolder position as the largest non-state-owned fuel storage and distribution business in the province.

For more information on Longwei Petroleum Investment Holding Ltd., please visit the company’s website at: www.LongweiPetroleum.com

About MissionIR

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Longhai Steel, Inc. (LGHS) Finds Success with 3-Pronged Growth Strategy

Longhai Steel, one of China’s leading producers of high-quality steel wire, has based its continuous revenue growth on a 3-pronged approach: Expanded Production, Acquisitions, Economy of Scale. It’s a strategy that has worked well for the rapidly growing company, with annual revenues increasing 60% from 2009 to 2011. Part of this is due to the company’s unbeatable location. Hebei province, which surrounds Beijing, is China’s biggest steel producing area, with all of the distributors and infrastructure in place for any size operation, and close to the nation’s construction activity. But Longhai’s multi-pronged growth plan has provided a secure diversity for expansion, avoiding growth that is too narrowly based.

• Expanded Production – Longhai recently began production from a newly constructed wire plant adjacent to its original plant. The new factory provides a capacity of 600,000 metric tons, increasing annual production capacity by 67% to 1.5 million metric tons. The new wire plant is designed to produce a higher grade wire than Longhai’s current products, producing wire from carbon steel, cold heading steel, and welding rod steel in diameters from 5.5 to 18 millimeters. The company has also acquired land adjacent to the two existing plants for addition of a third production facility.

• Acquisitions – Longhai intends to continue identifying modern, high-quality steel producers for acquisition at low valuations. The rapid growth of the industry in China has resulted in many small producers in the Hebei area that do not have the capital to expand. The government is actively supporting steel industry consolidation, and Longhai plans to expand its operations and sales by acquiring producers with production facilities near its current facilities.

• Economy of Scale – By expanding through organic growth, acquisitions, and modernizations, Longhai expects to increase its operating leverage, production, and sales, as well as have a greater influence on pricing and costs.

For additional information, visit the company’s website at www.LonghaiSteelInc.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

BioLineRx Ltd. (BLRX) Receives Extended Patent Protection on BL-1020

BioLineRx is a biopharmaceutical development company focused on building a portfolio of products for unmet medical needs or with advantages over currently available therapies. The company’s current portfolio consists of six clinical stage candidates: BL-1020 a first-in-class orally available treatment for schizophrenia, BL-8040 for treating acute myeloid leukemia, BL-7040 for treating inflammatory bowel disease, BL-1021 for neuropathic pain, BL-5010 for non-surgical removal of skin lesions, and BL-1040 for prevention of pathological cardiac remodeling following a heart attack.

The company announced today that a Notice of Allowance has been received from the United States Patent and Trademark Office claiming the crystalline form of its lead product, BL-1020. The patent, when granted, will be valid until at least 2031, without taking into account any possible extension periods, and is nine years longer than the granted patent coverage previously reported by BioLineRx. There are also patent applications pending in Europe, Japan, China, India, Australia, Brazil, Mexico, Canada, and Israel.

Right now, around 1 percent of the world’s population suffers from schizophrenia, most of whom suffer cognitive impairment which may affect daily functioning. Currently available schizophrenia therapies do not address this need. However, BL-1020 has shown to significantly improve cognitive function in schizophrenia patients. BioLineRx is currently conducting the Phase II/III CLARITY trial with the drug’s cognition enhancement as its primary objective. Results of the trial are expected sometime in the second half of 2013.

The company is pleased with the extended patent protection for its lead drug candidate, especially in the light of recent failures by larger pharmaceutical companies during late-stage clinical trials of schizophrenia drugs. In addition, many other pharmaceutical firms have reduced their operations surrounding schizophrenia therapies due to loss of patent protection.

For additional information about BioLineRX, BL-1020, and the company’s other drug candidates, please visit www.biolinerx.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Cardium Therapeutics, Inc. (CXM) Announces Upcoming Presentation at 2012 Noble Financial Life Sciences Investor Conference

Today before the opening bell, Cardium Therapeutics announced that Chairman & CEO Christopher J. Reinhard will be presenting at the BioX Noble Financial Life Sciences Exposition being held at the University of Connecticut, Stamford Campus on September 24 – 25, 2012.

A video webcast of the presentation, along with a copy of the slide deck, will be available shortly after the conference on Thursday, September 27, 2012, at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-calendar, as well as through the Noble Financial website at www.noblefcm.com. Microsoft SilverLight viewer will need to be installed to participate. The investor presentation is now available at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.

Cardium Therapeutics is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium’s current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company’s in-house MedPodium Health Sciences healthy lifestyle product platform.

To learn more about the company, visit www.cardiumthx.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

TriQuint Semiconductor, Inc. (TQNT) Wins $2.7M DARPA Contract to Triple Performance of Power Amplifiers

TriQuint Semiconductor recently announced that the company has been awarded a $2.7 million contract from DARPA for the express purpose of tripling the performance of gallium nitride (GaN) circuits. The Near Junction Thermal Transport (NJTT) project is the latest in DARPA’s Thermal Management Technologies program.

TriQuint, founded in 1985, is focused on providing RF solutions and foundry services for the communications, defense, and aerospace industries. TriQuint creates standard and custom products using gallium arsenide (GaAs), gallium nitride (GaN), surface acoustic wave, and bulk acoustic wave technologies. The company maintains facilities in the United States, production in Costa Rica, and design centers in North America and Germany.

The NJTT project is focused on thermal resistance at the ‘near junction’ of the transistor die as well as the device substrate, which can be responsible in devices for more than 50% of operational temperature increases. TriQuint will utilize its GaN on silicon carbide technology with diamond substrates as well as new thermal handling procedures. The company hopes this will reduce heat buildup and allow devices to generate more power. Lockheed Martin is slated to evaluate the results of the program.

James L. Klein, VP and GM for Infrastructure and Defense Products at TriQuint, said, “We are very pleased that DARPA selected TriQuint to develop this critical technology. Like other programs we have supported, NJTT will set the stage for substantial MMIC performance enhancements including reduced size, weight and power consumption while increasing reliability and output power.”

For more information on the company, visit www.triquint.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Repligen Corp. (RGEN) Appoints Jonathan Lieber as CFO and Treasurer

Repligen is pleased to announce that it has appointed Jonathan I. Lieber as its CFO and Treasurer, effective immediately. He will be responsible for leading Repligen’s financial activities, including long-term financial strategy and risk management. Repligen’s current CFO William J. Kelly will now serve as the company’s Chief Accounting Officer, overseeing Repligen’s internal controls and its accounting and management reporting functions.

In connection with Mr. Lieber’s appointment, the company granted him an inducement equity award outside of Repligen’s 2012 Stock Option and Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The award is for 15,000 shares of restricted stock which will vest in full on the first anniversary of Mr. Lieber’s start date.

“We are pleased to welcome Jonathan Lieber to the CFO role,” said Walter C. Herlihy, Ph.D., President and Chief Executive Officer at Repligen. “Over the past nine months, Repligen has become a profitable, significantly larger and more complex multinational organization. As the Company enters its next phase of growth, Mr. Lieber brings a particularly relevant skill set to the management team. His combined life sciences and capital markets expertise will be major assets to the Company as we advance on our strategy to further expand Repligen’s bioprocessing business and deliver top-tier financial performance.”

Most recently, Mr. Lieber was the CFO and Treasurer at Xcellerex, Inc., a supplier of bioprocessing products and disposable biomanufacturing technologies. Mr. Lieber led the company’s accounting, finance, legal, and corporate communications activities. He restructured the finance department and implemented business processes to support substantial revenue growth. Prior to Xcellerex, Mr. Lieber was with Altus Pharmaceuticals for seven years, most recently as Senior Vice President, CFO, and Treasurer. At Altus, he led all capital raising activities, resulting in net proceeds of $250 million, including its $110 million initial public offering.

Mr. Lieber has been involved in healthcare financings totaling over $3 billion in common stock and over $500 million in initial public offerings. He received a B.S. in business administration and finance from Boston University and an M.B.A. in finance from New York University Stern School of Business.

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Study Says Export Surge Could Help U.S. Add 5 Million Jobs by 2020

According to a study by the Boston Consulting Group, there is good news ahead for the U.S. economy thanks to cheap natural gas prices. The study claims rising U.S. factory productivity, spurred by low natural gas prices, could help the country boost exports of manufactured goods and add as many as five million manufacturing and support jobs by the end of the decade.

Low natural gas prices, driven by the shale boom, will give the United States a cost advantage versus other industrialized countries says Boston Consulting. By 2015, this factor will make average manufacturing costs in the U.S. lower by 15 percent when compared to Germany and France, 8 percent lower than the U.K. and 21 percent lower than Japan. Boston Consulting says, however, that manufacturing costs will still remain 7 percent lower in China.

U.S. factory employment has already rebounded a bit from the low hit in 2010 with employment growing by 3.6 percent to about 12 million people currently. Boston Consulting expects this on-shoring trend (moving manufacturing back to the U.S.) to continue as the United States becomes a more competitive exporter thanks to the glut of natural gas leading to falling prices for the fuel. Already some major U.S. firms, such as General Electric and Caterpillar, have brought jobs back home.

The consultancy forecasts that the United States could boost its exports by about $90 billion by 2020 by winning orders currently being filled by competitors in Europe and Japan. U.S. exports last year, according to government statistics, totaled $1.48 trillion. Based on its export forecast and worker productivity figures, Boston Consulting Group projects that the U.S. will add between 2.5 million and 5 million jobs by decade’s end which will aid in lowering the stubborn unemployment rate.

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

Dynatronics Corp. (DYNT) Introduces New SolarisPlus Product Line

Today, Dynatronics announced the introduction of its new line of Dynatron SolarisPlus products, which has been the result of a research and development initiative spanning three years. Four separate units make up the SolarisPlus product line: the SolarisPlus 709, 708, 706, and 705. These pioneering devices can provide seven waveforms of electrotherapy, as well as delivering Dynatronics’ patented three frequency ultrasound therapy and light therapy through a newly designed Tri-wave light probe and two light pads.

The company believes the Dynatron SolarisPlus units, its flagship products, are the most advanced devices of their kind on the market, representing the most powerful and versatile units available for the company’s practitioners and their patients.

The new, cutting-edge Tri-wave technology is comprised of red, infrared, and blue-wavelength light, delivered by means of two proprietary light pads for treating larger areas of the body or a light probe for treating smaller areas. The Tri-wave pads and light probes are substantially more powerful than their predecessors, offering a greater degree of flexibility in patient treatments. The Tri-wave devices have the capability of delivering seven different combinations of light therapy wavelengths, which enables practitioners to select the optimal treatment for each patient.

The SolarisPlus units can be mounted on a customized cart for easy transportation between clinic treatment stations. The new cart will be available in October.

The new SolarisPlus product line represents Dynatronics’ most comprehensive redesign project to date, updating the Solaris line that was originally introduced in 2003. The company anticipates the new products will stimulate higher sales of capital equipment.

Dynatronics is a manufacturer, marketer, and distributor of advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables, and rehabilitation equipment for the markets of physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology, and other related medical, cosmetic, and aesthetic fields.

For more information, visit the company’s Web site at www.dynatronics.com

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html

PROLOR Biotech, Inc. (PBTH) to Present Positive Phase 2 Data at ESPE2012

PROLOR Biotech, a biopharm company developing long-acting human growth hormone hGH-CTP, today announced that data from the company’s phase 2 trial of hGH-CTP for application to growth hormone deficient adults will be presented at ESPE 2012, the 51st Annual Meeting of the European Society for Pediatric Endocrinology.

The previously reported phase 2 study confirms hGH-CTP as a single weekly injection vs. the current standard-CTP of one injection per day. For a child receiving growth hormone replacement therapy, the total dosing by current daily standards would mean more than 3,000 injections before the age of 18.

“hGH-CTP has the potential to dramatically reduce this number, thereby making growth hormone therapy less burdensome and more feasible,” Dr. Abraham Havron, CEO of PROLOR stated in the press release. “We welcome the opportunity to raise awareness of our progress with hGH-CTP at this meeting of pediatric endocrinology opinion leaders.”

In addition, the study showed that 50%-65% of the cumulative weekly dose of conventional human growth hormone was required for the majority of the patients to remain within the normal range of IGF-1, a key biomarker of growth hormone activity.

In this trial, hGH-CTP demonstrated a good safety and tolerability profile. The treatment did not cause excessive IGF-1 levels in patients; nor was any IGF-I accumulation observed.

Positive phase 2 data in adults tipped the scale toward the company’s decision to continue with a phase 2 hGH-CTP trial in growth hormone deficient children that is currently enrolling patients.

The pediatric phase 2 trial is designed to compare the 12-month growth velocity of children receiving hGH-CTP injected once weekly with those receiving commercially available hGH injected daily.

The company’s poster, titled Once-Weekly, CTP-Modified hGH (MOD-4023) Effectively Maintains IGF-1 Levels Within the Normal Range in Growth Hormone Deficient Adults, Supporting Initiation of Clinical Development in Children, will be presented during the September 22, 2012 poster session of ESPE 2012 in Leipzig, Germany.

For more information visit www.prolor-biotech.com or visit www.espe2012.org

About MissionIR 

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.

Sign up for “The Mission Report” at www.MissionIR.com

Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html